.Five months after Rakovina Therapeutics pivoted toward expert system, the cancer-focused biotech ha...
.Ascendis Pharma has become a potential danger to BioMarin's Voxzogo, reporting stage 3 development ...
.Though Alkeus Pharmaceuticals' dental eye ailment resource stopped working to dramatically decrease...
.Along with a triad of biotechs hitting the Nasdaq on Friday, it was simple to overlook a smaller-sc...
.Invulnerable gate inhibitors are the superheroes of cancer treatment. Drugs like Bristol Myers Squi...
.Accept to this week's Chutes & Ladders, our summary of notable management hirings, shootings and...
.Regeneron is back with long-term follow-up for its own LAG-3 inhibitor as well as PD-1 prevention c...
.AstraZeneca has shared a very early examine the functionality of its in-house antibody-drug conjuga...
.After announcing a phase 3 launch based on good midstage outcomes, iTeos and GSK are lastly discuss...
.The FDA should be actually extra available and joint to unleash a surge in commendations of unusual...